Yes, of course.
We previously announced that we will have 23 million doses from Pfizer and Moderna during the second quarter. In the third quarter, we will be receiving more than 55 million doses. That will give us a total of 84 million doses from those two manufacturers alone.
Today, we added AstraZeneca to our portfolio of vaccines. The exact quantities we will receive during the second and third quarters still have to be confirmed. However, we can easily see that about 25 million doses will be added to our portfolio of vaccines starting in March, according to the announcement by the Serum Institute.
Those are some of the projections we have communicated to the provinces. Of course, we have to turn to the provinces quickly to tell them about the quantities we will be receiving shortly and to inform them about the distribution process. We want to avoid situations in which quantities arrive unannounced on a clinic's doorstep.
We will clearly have to plan quickly for the first deliveries of the doses from AstraZeneca.